Salvage Therapy of Refractory Hemophagocytic Lymphohistiocytosis with Alemtuzumab

BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome that remains difficult to treat. Even with current standard HLH therapy, only approximately half of patients will experience complete resolution of disease, and early mortality remains a significant...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Marsh, Rebecca A., Allen, Carl E., McClain, Kenneth L., Weinstein, Joanna L., Washko, Julie Kanter, Skiles, Jodi, Lee, Nadine D., Khan, Shakila P., Lawrence, Julia, Mo, Jun Q., Bleesing, Jack J., Filipovich, Alexandra H., Jordan, Michael B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3410971/
https://ncbi.nlm.nih.gov/pubmed/22522603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.24188
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados